Efficiency of PET-CT in Reducing the Usage of Radiotherapy in Childhood Hodgkin Lymphoma: A Single Center Experience

Connors JM, Cozen W, Steidl C et al (2020) Hodgkin lymphoma. Nat Rev Dis Primers 6(1):61

Article  PubMed  Google Scholar 

World Health Organization (2020) Estimated number of new cases in 2020, World, both sexes, all ages (excl. NMSC). Global Cancer Observatory. https://gco.iarc.fr. Accesed September 10, 2023

Glaser SL, Jarrett RF (1996) The epidemiology of Hodgkin’s disease. Baillieres Clin Haematol 9(3):401–416

Article  CAS  PubMed  Google Scholar 

Weniger MA, Küppers R (2021) Molecular biology of Hodgkin lymphoma. Leukemia 35(4):968–981

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kaseb H, Babiker HM, Hodgkin Lymphoma (2022) In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan

Stein H et al (2017) In: Swerdlow SH et al (eds) WHO classification of Tumours of Haematopoietic and lymphoid tissues, 4th edn. International Agency for Research on Cancer, pp 423–442

Carbone PP, Kaplan HS, Musshoff K, Smithers DW, Tubiana M (1971) Report of the Committee on Hodgkin’s Disease staging classification. Cancer Res 31(11):1860–1861

CAS  PubMed  Google Scholar 

Gobbi PG, Ferreri AJM, Ponzoni M, Levis A (2013) Hodgkin lymphoma. Crit Rev Oncol Hematol 85(2):216–237

Article  PubMed  Google Scholar 

Ansell SM, Hodgkin lymphoma (2020) A 2020 update on diagnosis, risk-stratification, and management. Am J Hematol 95(8):978–989

Article  PubMed  Google Scholar 

Kanoun S, Rossi C, Casasnovas O (2018) [18F]FDG-PET/CT in Hodgkin Lymphoma: current usefulness and perspectives. Cancers (Basel). 10(5)

Hutchings M, Loft A, Hansen M, Berthelsen AK, Specht L (2007) Clinical impact of FDG-PET/CT in the planning of radiotherapy for early-stage Hodgkin lymphoma. Eur J Haematol 78(3):206–212

Article  PubMed  Google Scholar 

Kurch L, Hasenclever D, Kluge R et al (2019) Only strongly enhanced residual FDG uptake in early response PET (Deauville 5 or qPET ≥ 2) is prognostic in pediatric Hodgkin lymphoma: results of the GPOH-HD2002 trial. Pediatr Blood Cancer. 66(3)

Burnelli R, Rinieri S, Rondelli R et al (2018) Long-term results of the AIEOP MH’96 childhood Hodgkin’s lymphoma trial and focus on significance of response to chemotherapy and its implication in low risk patients to avoid radiotherapy. Leuk Lymphoma 59(11):2612–2621

Article  PubMed  Google Scholar 

Mauz-Körholz C, Landman-Parker J, Balwierz W et al (2022) Response-adapted omission of radiotherapy and comparison of consolidation chemotherapy in children and adolescents with intermediate-stage and advanced-stage classical Hodgkin lymphoma (EuroNet-PHL-C1): a titration study with an open-label, embedded, multinational, non-inferiority, randomised controlled trial. Lancet Oncol 23(1):125–137

Article  PubMed  PubMed Central  Google Scholar 

Iyer VK (2013) Pediatric Lymphoma diagnosis: role of FNAC, Biopsy, immunohistochemistry and Molecular Diagnostics. Indian J Pediatr 80(9):756–763

Article  PubMed  Google Scholar 

McCarten KM, Nadel HR, Shulkin BL, Cho SY (2019) Imaging for diagnosis, staging and response assessment of Hodgkin lymphoma and non-hodgkin lymphoma. Pediatr Radiol 49(11):1545–1564

Article  PubMed  Google Scholar 

Kasamon YL, Jones RJ, Wahl RL (2007) Integrating PET and PET/CT into the risk-adapted therapy of lymphoma. J Nucl Med 48(Suppl 1):19S–27S

CAS  PubMed  Google Scholar 

Jerusalem G, Beguin Y, Fassotte MF et al (1999) Whole-body positron emission tomography using 18F-fluorodeoxyglucose for posttreatment evaluation in Hodgkin’s disease and non-hodgkin’s lymphoma has higher diagnostic and prognostic value than classical computed tomography scan imaging. Blood 94(2):429–433

Article  CAS  PubMed  Google Scholar 

Cheng G, Servaes S, Alavi A, Zhuang H (2008) FDG PET and PET/CT in the management of Pediatric Lymphoma patients. PET Clin 3(4):621–634

Article  PubMed  Google Scholar 

Elstrom RL, Leonard JP, Coleman M, Brown RKJ (2008) Combined PET and low-dose, noncontrast CT scanning obviates the need for additional diagnostic contrast-enhanced CT scans in patients undergoing staging or restaging for lymphoma. Ann Oncol 19(10):1770–1773

Article  CAS  PubMed  PubMed Central  Google Scholar 

Raanani P, Shasha Y, Perry C et al (2006) Is CT scan still necessary for staging in Hodgkin and non-hodgkin lymphoma patients in the PET/CT era? Ann Oncol 17(1):117–122

Article  CAS  PubMed  Google Scholar 

Hutchings M, Loft A, Hansen M et al (2006) Position emission tomography with or without computed tomography in the primary staging of Hodgkin’s lymphoma. Haematologica 91(4):482–489

PubMed  Google Scholar 

Rigacci L, Vitolo U, Nassi L et al (2007) Positron emission tomography in the staging of patients with Hodgkin’s lymphoma. A prospective multicentric study by the Intergruppo Italiano Linfomi. Ann Hematol 86(12):897–903

Article  PubMed  Google Scholar 

Engert A, Haverkamp H, Kobe C et al (2012) Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkin’s lymphoma (HD15 trial): a randomised, open-label, phase 3 non-inferiority trial. Lancet 379(9828):1791–1799

Article  CAS  PubMed  Google Scholar 

Cheson BD, Fisher RI, Barrington SF et al (2014) Recommendations for initial evaluation, staging, and Response Assessment of Hodgkin and Non-hodgkin Lymphoma: the Lugano classification. J Clin Oncol 32(27):3059–3067

Article  PubMed  PubMed Central  Google Scholar 

Barrington SF, Mikhaeel NG, Kostakoglu L et al (2014) Role of Imaging in the Staging and Response Assessment of Lymphoma: Consensus of the International Conference on Malignant Lymphomas Imaging Working Group. Journal of Clinical Oncology. 32(27):3048–3058

Totadri S, Radhakrishnan V, Ganesan TS et al (2018) Can Radiotherapy be omitted in children with Hodgkin Lymphoma who achieve metabolic remission on Interim Positron Emission Tomography? Experience of a Tertiary Care Cancer Referral Center. J Glob Oncol. (4):1–7

Palayullakandi A, Trehan A, Jain R et al (2022) Retrospective single-center experience with OEPA/COPDAC and PET-CT based strategy for pediatric Hodgkin lymphoma in a LMIC setting. Pediatr Hematol Oncol 39(7):587–599

Article  CAS  PubMed  Google Scholar 

Triumbari EKA, Gatta R, Maiolo E et al (2023) Baseline 18F-FDG PET/CT Radiomics in Classical Hodgkin’s lymphoma: the predictive role of the Largest and the hottest lesions. Diagnostics 13(8):1391

Article  CAS  PubMed  PubMed Central  Google Scholar 

El-Saban Kamalnm (2022) K. Role of 18F-FDG-PET/CT in assessment of pediatric Hodgkin’s lymphoma. Q J Nuclear Med Mol Imaging. 65(4)

Kalra M, Bakhshi S, Singh M et al (2023) Response assessment by positron emission tomography-computed tomography as compared with contrast-enhanced computed tomography in childhood Hodgkin lymphoma can reduce the need for radiotherapy in low- and middle-income countries. Pediatr Blood Cancer 70(2):e30091

Article  CAS  PubMed  Google Scholar 

Comments (0)

No login
gif